TECH — Bio-Techne Corporation
$72.80
+$0.04 (+0.05%)
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology.
Market Cap
$11.44B
Forward P/E
31.5x
52-Week Range
N/A
TECH Price History
Revenue vs. Net Income
$1.2B
Revenue · FY2026
Annual. Net margin is shown under each year.
Free Cash Flow
$263M
FCF · FY2026
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
10.3%
ROCE · FY2026
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
5.4x
Assets ÷ liabilities · FY2026
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
2.4%
CapEx · FY2026
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
-1.7%
Net buyback · FY2026
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
